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Background
Erdheim-Chester disease (ECD) is a rare non-Langerhans
cell histiocytosis (NLH), characterized by bilateral meta-
physeal sclerosis of long bones and visceral infiltration.
The histopathological hallmark is a xanthogranuloma-
tous infiltration of foamy CD68+ CD1a- histiocytes and
Touton giant cells. Only five paediatric cases have been
reported.
Materials and methods
We contacted all paediatric rheumatology and oncology
centers in France. Three cases of ECD have been identified.
We describe the clinical, radiological, histological charac-
teristics and treatments.
Results
All patients were female. Mean age at onset was 5 years
(patient A: 17 months, B: 7 years, C: 6 years). Mean diag-
nosis delay was 5 years. Initial presentation included
fever, bone pain (A and B), diabetes insipidus and growth
hormone deficiency (C) with sinus infiltration. B and C
developed retroperitoneal fibrosis with hydronephrosis
and renal failure in C. Patient A subsequently developed
exophtalmos. ECD was evoked on typical skeletal radiog-
raphies (A and B), and on retroperitoneal fibrosis on RMI
(B and C). ECD was confirmed histologically on biopsies
(retro-orbital/sinusal infiltration and bone). All patients
received corticosteroids, alone (B) or combined with
chemotherapy (A and C), which was partially and tempo-
rally effective. INFα was then used in all patients leading
to regression of lesions (B), stabilisation of disease (C)
and decrease of bone pains (A).
Conclusion
Although exceptional, paediatric ECD can be evoked in
case of NLH with long bone osteosclerosis and/or visceral
involvement. Prognosis depends of disease localisations
and their consequences. Treatment needs to be considered
case by case with special interest in IFNα.
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